Atlantic Life Sciences, Inc.


 

                  Information Medicale et Pharmacovigilance!
Vue d'ensemble
Volontaire
Stage
Forums
e-Bibliotheque
Carrière
Contact
  
Articles
DIA
  EMEA
FDA
Santé Canada
ICH 
WHO

 
Inscrivez-vous pour recevoir la mise à jour de cette page par E-mail

S'inscrire
  
WHO Documents et Articles pour L'Industrie Pharma&Biotech et Conduite Clinique
 Essential Drugs and Medicines Policy
Essential Medicines and Pharmaceutical Policies
HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP). GUIDANCE FOR IMPLEMENTATION. 2005
Annex 5. Guidelines for registration of fixed-dose combination medicinal products. June 2005
WHO EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS. Fortieth Report (WHO TRS No. 937): May 2006.
Annex 8: Proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms.WHO Technical Report Series, No. 937, 2006.
Annex 9: Additional guidance for organizations performing in vivo bioequivalence studies.WHO Technical Report Series, No. 937, 2006.
GOOD LABORATORY PRACTICE: TRAINING MANUAL FOR THE TRAINER
GOOD LABORATORY PRACTICE: TRAINING MANUAL FOR THE TRAINEE
REVISION/UPDATE OF THE GUIDANCE ON THE SELECTION OF COMPARATOR PHARMACEUTICAL PRODUCTS FOR EQUIVALENCE ASSESSMENT OF INTERCHANGEABLE MULTISOURCE (GENERIC) PRODUCTS. Draft Revision, 2005.
 

                      Go Back
©2003 - 2009, ALS Inc. All rights reserved